Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
ALZ.STthis companyAlzinova AB (publ)	SEK 0.33	-3.19×	0.68×	0×	-3.24×	-103.5%	0.0%	0.0%	0.0%	-21.5%	-20.9%	-47.5%	0.01×	-0.02×	-27.71×	0.11×	0.0%	3	5.43	2	C+
ACUC.STAcuCort AB	SEK 0.40	-2.73×	1.12×	103.97×	-1.68×	-33.7%	-2670.0%	-3856.3%	-3812.2%	-41.1%	-41.6%	-34.8%	0×	1.02×	-90.73×	8.08×	0.0%	3	9.81	1	C-
ANNX.STAnnexin Pharmaceuticals AB	SEK 9.40	-3.55×	5.25×	0×	-2.81×	-42.7%	0.0%	0.0%	0.0%	-148.0%	-145.6%	-28.3%	0×	0.74×	0×	5.47×	0.0%	1	-32.9	1	C-
BRAIN.STBrainCool AB (publ)	SEK 1.06	-3.95×	0.85×	4.14×	-3.68×	-1142.9%	-112.9%	-95.1%	-102.3%	-21.1%	-18.8%	-37.7%	0×	1.32×	-8.86×	7.03×	0.0%	2	22.35	1	C-
ISOFOL.STIsofol Medical AB (publ)	SEK 1.59	-2.92×	1.46×	0×	-2.12×	-85.2%	0.0%	0.0%	0.0%	-50.2%	-50.5%	-32.9%	0×	0.77×	-54,761×	6.19×	0.0%	2	-4.78	1	C-
KLAR.STKlaria Pharma Holding AB (publ.)	SEK 0.51	-3.17×	-31.79×	13.71×	-13.37×	-87.1%	-24.8%	-226.9%	-432.2%	1002.3%	625.9%	-28.4%	0×	0.04×	-1.49×	0.05×	0.0%	1	-4.07	2	C
Peer median	—	-3.17×	1.12×	4.14×	-2.81×	-85.2%	-24.8%	-95.1%	-102.3%	-41.1%	-41.6%	-32.9%	0×	0.77×	-8.86×	6.19×	0.0%	2	-4.07	1	—